{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:22:17Z","timestamp":1792718537612,"version":"4.5.0"},"reference-count":159,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"abstract":"<jats:p>\n                    In recent years, therapeutics targeted against KRAS proto\u2010oncogene GTPase (\n                    <jats:italic>KRAS<\/jats:italic>\n                    )\u2010mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of\n                    <jats:italic>KRAS<\/jats:italic>\n                    alterations at the lineage and allele levels, reviewing the clinical evidence for KRAS\n                    <jats:sup>G12C<\/jats:sup>\n                    inhibition from the discovery of the recessive switch pocket to sotorasib, adagrasib and other novel molecules, and extending to the non\u2010KRAS\n                    <jats:sup>G12C<\/jats:sup>\n                    era, including RAS (ON)\u2010 and KRAS\n                    <jats:sup>G12D<\/jats:sup>\n                    \u2010selective strategies and early efficacy signals. We summarize secondary mutations that lead to drug resistance, by\u2010pass reconnection, adaptive circuits and reprogramming of lineage\u2010cellular states. We propose a \u2018three\u2010clock, two\u2010window\u2019 framework, which includes half\u2010life exposure, occupation retention and extracellular signal\u2010regulated kinase (ERK) rebound calibration of dosing rhythm; a vascular normalization window and an immune\/myeloid plasticity window to achieve longitudinal Src homology 2\u2010containing protein tyrosine phosphatase 2\/son of sevenless homologue 1 and transverse epidermal growth factor receptor, phosphoinositide 3\u2010kinase\u2010protein kinase\u2010mammalian target of rapamycin synergy. At the same time, we construct and propose a closed loop of exposure, occupation, pathway inhibition, circulating tumour DNA (ctDNA) and imaging by utilizing ctDNA dynamics, phosphorylated ERK rebound and perfusion imaging, as well as myeloid lineage quantification, to improve durable inhibition and overall survival through time\u2010aligned combined effects.\n                  <\/jats:p>","DOI":"10.1111\/bph.70546","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:30:46Z","timestamp":1782952246000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting KRAS for cancer therapy"],"prefix":"10.1111","author":[{"given":"Jianlong","family":"Jia","sequence":"first","affiliation":[{"name":"Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich Member of the German Center for Lung Research (DZL)  Munich Germany"},{"name":"Department of Medicine V LMU University Hospital, LMU Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Liu","sequence":"additional","affiliation":[{"name":"Gene Center and Department of Biochemistry Ludwig\u2010Maximilians\u2010University (LMU)  Munich Germany"},{"name":"Institute of Infection and Immunity, College of Basic Medical Sciences Xi'an Jiaotong University  Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia A.","family":"Adamide","sequence":"additional","affiliation":[{"name":"Department of Pneumology Nicosia General Hospital  Strovolos Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis E.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich Member of the German Center for Lung Research (DZL)  Munich Germany"},{"name":"Department of Medicine V LMU University Hospital, LMU Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios T.","family":"Stathopoulos","sequence":"additional","affiliation":[{"name":"Department of Pneumology Nicosia General Hospital  Strovolos Cyprus"},{"name":"Medical School University of Cyprus  Aglantzia Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70230"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70233"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70234"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70229"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52324-3"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00745-0"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101839"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-023-01410-2"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105281"},{"issue":"1","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the KRAS\/RAF\/MAPK pathway for cancer therapy: From mechanism to clinical studies","volume":"8","author":"Bahar M. E.","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040901"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00866-9"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.04.025"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00434"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.3005"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00605"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.8510"},{"issue":"7511","key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research, N","year":"2014","journal-title":"Nature"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1694-1"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.9007"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01194-4"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03688-6"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.05.013"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.21037\/apc-24-2"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl6464"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3125.RAS23-B025"},{"issue":"6","key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1021\/acs.jmedchem.4c02313","article-title":"Discovery of Elironrasib (RMC\u20106291), a potent and orally bioavailable, KRAS (ON) G12C\u2010selective, covalent tricomplex inhibitor for the treatment of patients with KRAS G12C\u2010addicted cancers","volume":"68","author":"Cregg J.","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00221-0"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2023.100743"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02696-8"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0177"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108683"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605943"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.01.004"},{"issue":"7","key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/2159-8290.CD-25-0349","article-title":"Response and resistance to KRAS inhibition in cancer","volume":"15","author":"Ebright R. Y.","year":"2025","journal-title":"Cancer Discovery"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-ND06"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00605-7"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308795"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.022"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201414"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14988"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03221-2"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.066"},{"issue":"4","key":"e_1_2_11_46_1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.4_suppl.722","article-title":"Safety, efficacy, and on\u2010treatment circulating tumor DNA (ctDNA) changes from a phase 1 study of RMC\u20106236, a KRAS (ON) multi\u2010selective, tri\u2010complex inhibitor, in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC)","volume":"43","author":"Garrido\u2010Laguna I.","year":"2025","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"e_1_2_11_47_1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.chembiol.2017.08.025","article-title":"KRAS binder induces a modified Switch\u2010II pocket in GTP and GDP states","volume":"24","author":"Gentile D. R.","year":"2017","journal-title":"Cell Chemistry & Biology"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4183"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-1313"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-4373"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.03.008"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108889"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1006"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0142"},{"issue":"8013","key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent inhibition of oncogenic and wild\u2010type KRAS\u2010GTP for cancer therapy","volume":"629","author":"Holderfield M.","year":"2024","journal-title":"Nature"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.3_suppl.94"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917239"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-15-0203"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.11.009"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113458"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-23-PR014"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.8500"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3438"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00681-z"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.12412"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0033"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.79"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1386"},{"issue":"4","key":"e_1_2_11_70_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","article-title":"Protective autophagy elicited by RAF\u2010\u2010>MEK\u2010\u2010>ERK inhibition suggests a treatment strategy for KRAS\u2010driven cancers","volume":"25","author":"Kinsey C. G.","year":"2019","journal-title":"Nature Medicine"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.04.015"},{"issue":"6","key":"e_1_2_11_72_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with KRAS by programming inflammation and immune suppression","volume":"171","author":"Kortlever R. M.","year":"2017","journal-title":"Cell"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02717-6"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.09.635"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00334-z"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119662"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.025"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.3_suppl.604"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265715"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268244"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.072"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0289"},{"issue":"18","key":"e_1_2_11_83_1","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1039\/C5CS00911A","article-title":"Drugging KRAS GTPase: A comprehensive mechanistic and signaling structural view","volume":"45","author":"Lu S.","year":"2016","journal-title":"Chemical Society Reviews"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-CT022"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0840"},{"issue":"1","key":"e_1_2_11_86_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03051-z","article-title":"Myeloid\u2010derived interleukin\u20101beta drives oncogenic KRAS\u2010NF\u2010kappaBeta addiction in malignant pleural effusion","volume":"9","author":"Marazioti A.","year":"2018","journal-title":"Nature Communications"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep25931"},{"issue":"6","key":"e_1_2_11_88_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The KRAS\u2010ERK and PI3K\u2010mTOR pathways: Cross\u2010talk and compensation","volume":"36","author":"Mendoza M. C.","year":"2011","journal-title":"Trends in Biochemical Sciences"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00352-3"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.02.012"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8780"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-CT028"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2198"},{"issue":"36","key":"e_1_2_11_94_1","doi-asserted-by":"crossref","first-page":"19718","DOI":"10.1016\/S0021-9258(19)77694-7","article-title":"Kinetic analysis of the hydrolysis of GTP by p21N\u2010KRAS. The basal GTPase mechanism","volume":"263","author":"Neal S. E.","year":"1988","journal-title":"The Journal of Biological Chemistry"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-1420"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.09.151"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-2310"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00046"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00830-3"},{"issue":"7477","key":"e_1_2_11_100_1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K\u2010KRAS(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem J. M.","year":"2013","journal-title":"Nature"},{"issue":"6","key":"e_1_2_11_101_1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0092-8674(00)00196-3","article-title":"Crystal structure and functional analysis of KRAS binding to its effector phosphoinositide 3\u2010kinase gamma","volume":"103","author":"Pacold M. E.","year":"2000","journal-title":"Cell"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02760-3"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.675"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.9508"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0795"},{"issue":"5","key":"e_1_2_11_106_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41568-024-00679-6","article-title":"Combinatorial strategies to target KRAS\u2010driven cancers","volume":"24","author":"Perurena N.","year":"2024","journal-title":"Nature Reviews. Cancer"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02026"},{"issue":"14","key":"e_1_2_11_108_1","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","article-title":"The frequency of KRAS mutations in cancer","volume":"80","author":"Prior I. A.","year":"2020","journal-title":"Cancer Research"},{"issue":"10","key":"e_1_2_11_109_1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in KRAS\u2010targeted cancer therapies","volume":"19","author":"Punekar S. R.","year":"2022","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"11","key":"e_1_2_11_110_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"KRAS oncogenes: Weaving a tumorigenic web","volume":"11","author":"Pylayeva\u2010Gupta Y.","year":"2011","journal-title":"Nature Reviews. Cancer"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908353116"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20230277"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3MD00145H"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.005"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.013"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10091"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.3563"},{"issue":"12","key":"e_1_2_11_118_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110993","article-title":"KRAS(G12C)\u2010independent feedback activation of wild\u2010type KRAS constrains KRAS(G12C) inhibitor efficacy","volume":"39","author":"Ryan M. B.","year":"2022","journal-title":"Cell Reports"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3523"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303810"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.075"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00040"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9787-9"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.035"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg9652"},{"issue":"1","key":"e_1_2_11_126_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"KRAS proteins and their regulators in human disease","volume":"170","author":"Simanshu D. K.","year":"2017","journal-title":"Cell"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02903-0"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0099"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03732-5"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103695"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0814"},{"issue":"5","key":"e_1_2_11_132_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","article-title":"KRAS\u2010induced interleukin\u20108 expression plays a critical role in tumor growth and angiogenesis","volume":"6","author":"Sparmann A.","year":"2004","journal-title":"Cancer Cell"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061866"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.724"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.014"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46040177"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208470"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0369"},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e15088"},{"key":"e_1_2_11_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00800-6"},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1518808112"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.01.012"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00928361"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06907"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-00985-w"},{"key":"e_1_2_11_146_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03876-4"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030259"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm988"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.1741"},{"key":"e_1_2_11_150_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0217"},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212419"},{"key":"e_1_2_11_152_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-022-00718-0"},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00978"},{"key":"e_1_2_11_154_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06864-x"},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02315-7"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.07.010"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0006"},{"issue":"1","key":"e_1_2_11_158_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41589-024-01684-4","article-title":"Single\u2010cell sensor analyses reveal signaling programs enabling KRAS\u2010G12C drug resistance","volume":"21","author":"Zhang J. Z.","year":"2025","journal-title":"Nature Chemical Biology"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3008"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.584"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.70546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bph.70546","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.70546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:30:50Z","timestamp":1782952250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.70546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":159,"alternative-id":["10.1111\/bph.70546"],"URL":"https:\/\/doi.org\/10.1111\/bph.70546","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bph.70546"}}